Professional Documents
Culture Documents
Picking Up The Pace of A Slow Heartbeat: Presented By: Insert Physician Name/Title
Picking Up The Pace of A Slow Heartbeat: Presented By: Insert Physician Name/Title
• Neurological diseases
30,000
>
times
PO
F ©iStockphoto.com
©iStockphoto.com
1. Faris OP, Shein M. Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter‐defibrillator patients. Circulation 2006;114:1232‐1233.
2. Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336 ‐346.
3. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on
Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology
Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878‐2891.
4. Kalin R and Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. PACE 2005;28:326 ‐328.
50-75%
probability that cardiac device patients
will be indicated for an MRI over the
lifetime of their devices6
5. Medtronic calculations cited in Rod Gimbel and Ted McKenna, “Safety of Implantable Pacemakers and Cardioverter Defibrillators in the Magnetic Resonance Imaging Environment,”
Business Briefing: Long‐Term Healthcare 2005 (2005) available at www.touchbriefings.co
6. Kalin R and Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. PACE 2005;28:326‐328.
* Commonly used to diagnose strokes, cancer, Alzheimer’s disease, muscle, bone and back pain – all commonly seen as we age
8. Sutton R, Kanal E, Wilkoff BL, Bello D, et al. Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design. Trials 2008, 9:68.
9. IMV, “Benchmark Report: MRI 2007,” IMV Medical Information Division. Des Plaines, IL. 2008
Ask me
questions!
©iStockphoto.com
10. National Council on Aging (NCOA) Survey on Medical Imaging Safety, February 2011.
• Risks associated with pacemaker system implant include, but are not limited to, infection at the surgical site
and/or sensitivity to the device material, failure to deliver therapy when it is needed, or receiving extra therapy
when it is not needed. After receiving an implantable pacemaker system, you will have limitations with magnetic
and electromagnetic radiation, electric or gas powered appliances, and tools with which you are allowed to be in
contact.
• A complete SureScan pacing system including a Revo MRI SureScan IPG and two CapSureFix MRI SureScan
leads is required for use in the MRI environment. Any other pacing system combination may result in a hazard to
the patient during an MRI scan. When programmed to On, the MRI SureScan feature allows the patient to be
safely scanned while the device continues to provide appropriate pacing. The Revo MRI SureScan pacing system
is MR Conditional. This means the pacing system is designed to allow patients to undergo MRI, when your doctor
determines you meet patient eligibility requirements and the scan is conducted according to Medtronic directions.
• This treatment is prescribed by your physician. This treatment is not for everyone. Please talk to your doctor to
see if it is right for you. Your physician should discuss all potential benefits and risks with you. Although many
patients benefit from the use of this treatment, results may vary.